Albemarle has pulled back sharply from recent highs, bringing the world’s largest lithium producer back into more interesting territory. We previously owned ALB in the International Equities Portfolio, selling at ~$163. While that proved a little early as the stock continued higher, the subsequent retreat to around ~$130 has again put it on our Hitlist.
The near-term lithium picture remains finely balanced. On one hand, the demand story is still intact, supported by EV growth, battery storage and the broader electrification thematic. On the other hand, the recent rally in lithium prices and lithium equities risks encouraging mothballed supply to return to market, which could cap the upside in the short term. In our view, that makes the next leg for lithium more 50/50 than one-way traffic.
However, the medium-term setup remains attractive. The industry has endured a brutal downturn, capital has been pulled back, balance sheets have been tested, and high-cost production has been forced out. That is usually how commodity cycles repair themselves. Albemarle is one of the highest-quality ways to play that recovery, with scale, integrated assets and material earnings leverage if lithium prices continue to normalise.
The numbers highlight that leverage. Bloomberg consensus has ALB’s adjusted EPS recovering from a loss in FY25 to more than US$12/share in FY26, with EBITDA expected to lift from around US$1.1bn in FY25 to ~US$2.9bn in FY26 and free cash flow improving materially. On those estimates, the stock is trading on around 10x FY26 earnings and ~6x FY26 EV/EBITDA, which is not demanding if the lithium recovery has legs.
Brokers are bullish, with Bloomberg consensus showing 60% buys, 40% holds and no sells, while the 12-month consensus target price sits around US$220, implying meaningful upside from current levels. We are always cautious with consensus targets in commodity names — they move quickly with spot prices — but they do reinforce the point that ALB is no longer priced like it was a few months ago.
The read-through for the ASX lithium names is similar. Pilbara Minerals (PLS), Mineral Resources (MIN), IGO Ltd (IGO) and Liontown (LTR) all remain highly leveraged to the same lithium price cycle. If supply discipline holds and demand continues to build, these stocks should remain well supported. If higher prices drag idle supply back into the market too quickly, the sector could struggle to make sustained progress in the short term.
We hate sitting on the fence at MM; however, we don’t think ALB and the rest of the lithium sector are a screaming buy today, but it is back in the zone where the risk/reward is becoming more attractive. We remain cautious on lithium in the very short term given the likelihood of supply response, but medium term we continue to like the thematic.
- For now, ALB sits firmly back on the hitlist, with lower levels offering a more compelling entry point into one of the highest-quality lithium exposures globally.
